Skeletal-related events (SREs) are important measures of morbidity and mortality in patients with solid tumour bone metastases. The high rate of SREs in patients with differentiated thyroid cancer bone metastases reported by Farooki et al. indicates that routine use of antiresorptive therapy in these patients could result in reduced SREs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosen, L. S. et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J. Clin. Oncol. 21, 3150–3157 (2003).
Henry, D. H. et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J. Clin. Oncol. 29, 1125–1132 (2011).
Durante, C. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892–2899 (2006).
Farooki, A., Leung, V., Tala, H. & Tuttle, R. M. Skeletal-related events due to bone metastases from differentiated thyroid cancer. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2012-1169.
Orita, Y., Sugitani, I., Toda, K., Manabe, J. & Fujimoto, Y. Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid 21, 31–35 (2011).
Domchek, S. M., Younger, J., Finkelstein, D. M. & Seiden, M. V. Predictors of skeletal complications in patients with metastatic breast carcinoma. Cancer 89, 363–368 (2000).
Coleman, R. E. Bisphosphonates: clinical experience. Oncologist 9 (Suppl. 4), 14–27 (2004).
Kazaure, H. S., Roman, S. A. & Sosa, J. A. Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival. Cancer 118, 3260–3267 (2012).
Muresan, M. M. et al. Bone metastases from differentiated thyroid carcinoma. Endocr. Relat Cancer 15, 37–49 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gramza, A., Kebebew, E. Thyroid cancer bone metastases and high morbidity rates. Nat Rev Endocrinol 8, 454–455 (2012). https://doi.org/10.1038/nrendo.2012.112
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.112
